F1 antigenaemia in bubonic plague patients, a marker of gravity and efficacy of therapy

被引:24
作者
Chanteau, S
Rabarijaona, L
O'Brien, T
Rahalison, L
Hager, J
Boisier, P
Burans, J
Rasolomaharo, M
机构
[1] Inst Pasteur, Antananarivo, Madagascar
[2] USN, Med Res Inst, Bethesda, MD 20814 USA
[3] Naval Med Res Unit 2, Jakarta, Indonesia
[4] Androva Hosp, Mahajanga, Madagascar
关键词
plague; Yersina pestis;
D O I
10.1016/S0035-9203(98)90923-3
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
[No abstract available]
引用
收藏
页码:572 / 573
页数:2
相关论文
共 9 条
[1]   Urban epidemic of bubonic plague in Majunga, Madagascar: Epidemiological aspects [J].
Boisier, P ;
Rasolomaharo, M ;
Ranaivoson, G ;
Rasoamanana, B ;
Rakoto, L ;
Andrianirina, Z ;
Andriamahefazafy, B ;
Chanteau, S .
TROPICAL MEDICINE & INTERNATIONAL HEALTH, 1997, 2 (05) :422-427
[2]  
Brubaker R R, 1972, Curr Top Microbiol Immunol, V57, P111
[3]   Plague, a reemerging disease in Madagascar [J].
Chanteau, S ;
Ratsifasoamanana, L ;
Rasoamanana, B ;
Rahalison, L ;
Randriambelosoa, J ;
Roux, J ;
Rabeson, D .
EMERGING INFECTIOUS DISEASES, 1998, 4 (01) :101-104
[4]   Field evaluation of an immunoglobulin G anti-F1 enzyme-linked immunosorbent assay for serodiagnosis of human plague in Madagascar [J].
Rasoamanana, B ;
Leroy, F ;
Boisier, P ;
Rasolomaharo, M ;
Buchy, P ;
Carniel, E ;
Chanteau, S .
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 1997, 4 (05) :587-591
[5]  
Ribes G. C. de, 1997, Cahiers d'Etudes et de Recherches Francophones/Sante, V7, P53
[6]  
*WHO, 1970, WHO TECHN REP SER, V447
[7]  
WILLIAMS JE, 1986, B WORLD HEALTH ORGAN, V64, P745
[8]  
WILLIAMS JE, 1984, B WORLD HEALTH ORGAN, V62, P463
[9]  
World Health Organization, 1996, WKLY EPIDEMIOL REC, V71, P165